Protalix BioTherapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-31.4M |
| Depreciation & Amortization | — |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $2.7M |
| Net Cash from Operating Activities | $44.5M |
| Investing Activities | |
| Capital Expenditures | $6.2M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-6.2M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $293.0K |
| Net Change in Cash | $38.7M |
| Free Cash Flow | $38.3M |